FDMT

FDMT Net Income Growth

8.65%TTM

Period ending:

FDMT TTM Net Income YoY %%
FDMT TTM Net Income YoY %65.95%-467.90%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

FDMT net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

4D Molecular Therapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
8.6513%
8.8087%
12.9044%
-45.7883%
-78.4863%
-68.7507%
-59.5327%
-49.5627%
1.3244%
4.8089%
6.1929%
8.8072%
-9.4569%
-35.1869%
-50.727%
-57.5268%
-94.2644%
-35.5528%
-25.7951%
-27.7836%
14.2841%
-10.5722%
-14.9819%
-47.7405%
-192.6249%
-256.2566%
-416.2391%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All FDMT financial metrics · FDMT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.